Why Bacterial Metabolites Could Be a Biomarker for Parkinson Disease - Neurology Advisor

Researchers sought to analyze bacterial-derived metabolites, particularly TMAO pathway and SCFA, of patients with PD and compare the metabolites with control individuals within their households and patients with MSA.

Bacterial metabolites may be a biomarker of Parkinson disease (PD), according to a study published in Neurobiology of Disease. The etiopathogenesis of PD is unclear, but it appears to involve severa… [+2850 chars]

full article...